Hypertonicity counteracts MCL-1 and renders BCL-XL a synthetic lethal target in head and neck cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Research

Background:

• Head and neck squamous cell carcinoma (HNSCC) is aggressive and challenging to treat.
• Current therapies target the intrinsic apoptosis pathway, but resistance is common due to complex signaling and microenvironment factors.
• The BCL-2 protein family regulates apoptosis thresholds, influencing cancer cell sensitivity to treatment.

Purpose of the Study:

• To investigate the role of hyperosmotic stress in HNSCC cell death.
• To identify mechanisms by which HNSCC cells respond to environmental stress.
• To explore novel therapeutic targets for HNSCC.

Main Methods:

• Induction of hyperosmotic stress in HNSCC cell lines.
• Analysis of NOXA protein expression and its effect on BCL-2 family interactions.
• Assessment of cell sensitivity to BCL-XL inhibition.
• Evaluation of MCL-1 functional loss under hypertonic conditions.

Main Results:

• HNSCC cells upregulate the proapoptotic protein NOXA in response to hyperosmotic stress.
• NOXA induction counteracts MCL-1's antiapoptotic function, leading to BCL-XL dependency.
• Hypertonicity-induced MCL-1 loss makes BCL-XL a synthetic lethal target in HNSCC.
• BCL-XL inhibition effectively kills HNSCC cells resistant to conventional therapies.

Conclusions:

• Hyperosmotic stress induces NOXA, linking tumor microenvironment osmotic pressure to mitochondrial priming.
• Targeting BCL-XL in HNSCC, particularly under conditions of hypertonicity, represents a promising therapeutic strategy.
• This approach could enhance the efficacy of existing anticancer drugs for HNSCC.